| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1515/CCLM.2003.214 |
| P8608 | Fatcat ID | release_opb7lzxn3jevhayqameex5ikva |
| P698 | PubMed publication ID | 14656016 |
| P50 | author | Martin Weger | Q115801481 |
| P2093 | author name string | Brian Fowler | |
| Jürgen Geisel | |||
| Wolfgang Herrmann | |||
| Klaus Pietrzik | |||
| Olaf Stanger | |||
| Jutta Dierkes | |||
| DACH-LIGA Homocystein e.V | |||
| P2860 | cites work | A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 |
| Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders | Q24336993 | ||
| A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida | Q28141956 | ||
| Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme | Q28180489 | ||
| Homocysteine and cardiovascular disease | Q28265188 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects | Q31720591 | ||
| Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies | Q34060588 | ||
| ??? | Q57782093 | ||
| Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis | Q34160359 | ||
| Impaired homocysteine metabolism and atherothrombotic disease | Q34249956 | ||
| Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease | Q34395823 | ||
| Physiology of folic acid in health and disease | Q34633034 | ||
| Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia | Q34716812 | ||
| The natural history of vascular disease in homocystinuria and the effects of treatment | Q34741462 | ||
| Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us? | Q34809311 | ||
| MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. | Q34974721 | ||
| Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. | Q34995526 | ||
| The economic burden of coronary heart disease in the UK. | Q35580657 | ||
| Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease | Q35706295 | ||
| The effect of a subnormal vitamin B-6 status on homocysteine metabolism | Q37357164 | ||
| Vitamin B6 safety issues | Q37934243 | ||
| Novel functions of vitamin B6. | Q40609853 | ||
| Folate intake in Europe: recommended, actual and desired intake | Q41623676 | ||
| Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background | Q41636541 | ||
| Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? | Q43672916 | ||
| Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond | Q43709661 | ||
| Decreased rate of coronary restenosis after lowering of plasma homocysteine levels | Q43834213 | ||
| Vitamins--dietary intake and intake from dietary supplements in Germany | Q44007735 | ||
| Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study | Q44036308 | ||
| Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial | Q44110828 | ||
| Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease | Q44120526 | ||
| Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects | Q44138889 | ||
| Smoking and plasma homocysteine | Q44152695 | ||
| Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects | Q44286470 | ||
| Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes | Q44326347 | ||
| Serum folate and chronic disease risk: findings from a cohort of United States adults | Q44544432 | ||
| Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. | Q50539803 | ||
| Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. | Q51559556 | ||
| Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study | Q56115575 | ||
| A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes | Q56171250 | ||
| Assessing the Clinical and Economic Burden of Coronary Artery Disease: 1986-1998 | Q56928569 | ||
| Potential Clinical and Economic Effects of Homocyst(e)ine Lowering | Q57267999 | ||
| Folic acid fortification of grain: an economic analysis | Q57317338 | ||
| Lifetime risk of developing coronary heart disease | Q57414036 | ||
| Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women | Q57751240 | ||
| Folic acid fortification of the food supply. Potential benefits and risks for the elderly population | Q58580179 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| folic acid | Q127060 | ||
| vitamin B | Q183206 | ||
| P304 | page(s) | 1392-1403 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Clinical Chemistry and Laboratory Medicine | Q5133754 |
| P1476 | title | DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations | |
| P478 | volume | 41 |
| Q35585755 | A review of the effect of diet on cardiovascular calcification |
| Q56988061 | Antioxidant intake from diet and supplements and elevated serum C-reactive protein and plasma homocysteine concentrations in US adults: a cross-sectional study |
| Q89422763 | Application of conicity index adjusted total body fat in young adults-a novel method to assess metabolic diseases risk |
| Q43697511 | Association of MTHFR gene C677T mutation with recurrent aphthous stomatitis and number of oral ulcers |
| Q43165536 | Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart |
| Q82312471 | Association of hyperhomocysteinemia with liver steatosis in patients with chronic hepatitis C |
| Q36635197 | Association of plasma homocysteine with self-reported sleep apnea is confounded by age: results from the national health and nutrition examination survey 2005-2006. |
| Q55438718 | Association of total homocysteine with blood pressure in a general population of Chinese adults: a cross-sectional study in Jiangsu province, China. |
| Q47900388 | Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease |
| Q45138816 | C677T methylene-tetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinaemia |
| Q88607631 | CME-Labor 51/Auflösung: Beurteilung des Folatstatus |
| Q35946147 | Cobalamin: a critical vitamin in the elderly |
| Q36098392 | Determining Functional Vitamin B12 Deficiency in the Elderly |
| Q31006990 | Diet and psoriasis: experimental data and clinical evidence |
| Q90670709 | Effect of Moxibustion on Hyperhomocysteinemia and Oxidative Stress Induced by High-Methionine Diet |
| Q43065126 | Effect of entacapone on plasma homocysteine levels in Parkinson's disease patients |
| Q58545775 | Effect of long-term low-dose folic acid supplementation on degree of total homocysteine-lowering: major effect modifiers |
| Q38351083 | Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials. |
| Q36268221 | Effects of an L-arginine-based multi ingredient product on endothelial function in subjects with mild to moderate hypertension and hyperhomocysteinemia - a randomized, double-blind, placebo-controlled, cross-over trial |
| Q46202671 | Efficacy of flour fortification with folic acid in women of childbearing age in Iran |
| Q47422208 | Elevated Plasma Homocysteine Level Increased the Risk of Early Renal Impairment in Acute Ischemic Stroke Patients |
| Q43297671 | Elevated cerebrospinal fluid and plasma homocysteine levels in ALS. |
| Q59649454 | Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender |
| Q43108176 | Excess dietary methionine does not affect fracture healing in mice. |
| Q37232270 | Factors associated with serum total homocysteine level in type 2 diabetes |
| Q37279897 | HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE. |
| Q51540654 | Homocysteine and asymmetric dimethylarginine in relation to B vitamins in elderly people. |
| Q42238968 | Homocysteine in dogs with systemic inflammatory response syndrome. |
| Q36548650 | Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults |
| Q46384464 | Homocysteine measurement by an enzymatic method and potential role of homocysteine as a biomarker in dogs |
| Q37027541 | Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review |
| Q51494516 | Homocysteine, folate and vitamin b12 in patients with coronary heart disease. |
| Q36177626 | Hyperhomocysteinemia and the role of B vitamins in cancer |
| Q37601899 | Hyperhomocysteinemia in Greyhounds and its Association with Hypofolatemia and Other Clinicopathologic Variables |
| Q44576863 | Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia |
| Q43117573 | Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis |
| Q37033798 | Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study |
| Q33436487 | Laboratory tests for diagnosing and monitoring canine leishmaniasis |
| Q35761415 | Long-term effect of Helicobacter pylori eradication on plasma homocysteine in elderly patients with cobalamin deficiency. |
| Q40111907 | Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions |
| Q47322078 | Methylenetetrahydrofolate reductase polymorphism associated with moderate hyperhomocysteinaemia in a patient with livedo vasculopathy: treatment with vitamin supplementation and low molecular weight heparin |
| Q34051608 | Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia |
| Q43439109 | Modern society and prospects of low vitamin B12 intake |
| Q36297109 | Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss |
| Q35632011 | Plasma Homocysteine is Not Related to the Severity of Microangiopathy in Secondary Raynaud Phenomenon |
| Q34512180 | Plasma homocysteine and B vitamins levels in Nigerian children with nephrotic syndrome |
| Q46656563 | Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism |
| Q53108050 | Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years. |
| Q28222440 | Prophylactic treatment of preeclampsia |
| Q33730307 | Revised D-A-CH intake recommendations for folate: how much is needed? |
| Q86408338 | Serum homocysteine and methylmalonic acid concentrations in Chinese Shar-Pei dogs with cobalamin deficiency |
| Q36388302 | Specific reactions of S-nitrosothiols with cysteine hydrolases: A comparative study between dimethylargininase-1 and CTP synthetase |
| Q34070513 | Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia |
| Q30318724 | Study of molecular targets influencing homocysteine and cholesterol metabolism in growing rats by manipulation of dietary selenium and methionine concentrations |
| Q42366203 | The Impact of Homocysteine, Vitamin B12, and Vitamin D Levels on Functional Outcome after First-Ever Ischaemic Stroke |
| Q33384532 | The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study |
| Q42857837 | The association between dietary intake of folate and physical activity with psychological dimensions of depressive symptoms among students from Iran. |
| Q43265873 | The association between high plasma homocysteine levels and lower bone mineral density in Slovak women: the impact of vegetarian diet |
| Q46894818 | The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial |
| Q34978212 | The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial |
| Q45184549 | The impact of genetic and environmental factors on homocysteine levels in preterm neonates. |
| Q37027538 | The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review |
| Q50692041 | Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance. |
| Q40127118 | Total homocysteine, B-vitamins and genetic polymorphisms in patients with classical phenylketonuria. |
| Q46863161 | Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors |
| Q36541598 | Vitamin B12 and health |
| Q44542793 | Vitamin status in elderly people in relation to the use of nutritional supplements |
Search more.